Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Anatomic Stage II Breast Cancer AJCC v8
0.010 Biomarker disease BEFREE CCL5 could be considered as a biomarker for disease progression in stage II breast cancer patients, with the CCL5(+)/ER-alpha(-) combination providing improved prediction of disease progression, primarily in the stage IIA subgroup. 16899591 2006